Duality Advisers’s Agios Pharmaceuticals AGIO Stock Holding History

Duality Advisers’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-24,659	Closed	-$566K	–	503
2023 Q1	$566K	Buy	+24,659	New	+$655K	0.06%	386
2022 Q1	–	Sell	-54,530	Closed	-$1.79M	–	618
2021 Q4	$1.79M	Buy	+54,530	New	+$2.19M	0.19%	197
2021 Q3	–	Sell	-23,380	Closed	-$1.29M	–	508
2021 Q2	$1.29M	Buy	+23,380	New	+$1.31M	0.11%	293
2020 Q4	–	Sell	-34,290	Closed	-$1.2M	–	531
2020 Q3	$1.2M	Buy	+34,290	New	+$1.5M	0.08%	331

Other funds holding AGIO

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Duality Advisers's AGIO Position: Q2 2023 in Review

Duality Advisers sold out of Agios Pharmaceuticals (AGIO) in Q2 2023, closing a stake of 24,659 shares — an estimated $566K sold.

Duality Advisers first reported a position in AGIO in Q3 2020 and held it in 4 quarters. The position peaked at $1.79M in Q4 2021. 153 funds tracked by Wall St. Rank hold AGIO as of Q2 2023.

Duality Advisers reported no remaining Agios Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
Duality Advisers sold 24,659 Agios Pharmaceuticals shares in Q2 2023, an estimated $566K.
Duality Advisers first reported a position in Agios Pharmaceuticals in Q3 2020 and held it in 4 quarters.
Duality Advisers's Agios Pharmaceuticals position peaked at $1.79M in Q4 2021.
153 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2023.

Based on Duality Advisers's 13F filing for Q2 2023, filed 31 Jul 2023.